- After Moderna stock surge of 177% on cancer drug breakthrough, here's what Wall Street thinks happens next Yahoo Finance
- How Moderna Nearly Tripled Its Stock Price in a Single Day The New York Times
- Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar CNBC
- Moderna’s 177% Surge Burns Shorts in ‘Painful’ $5.5 Billion Loss Bloomberg.com
- Merck-Moderna cancer vaccine win spurs stock jump, speculation of Keytruda-like impact Fierce Biotech
Рекомендовані коментарі
Для публікації повідомлень створіть обліковий запис або авторизуйтесь